Those results suggested that interrupt of Trp metabolism/c-Myc loop by c-Myc inhibitor could strengthen the anticancer effects of the chemotherapy, providing an innovative approach in clinical prostatic cancer therapy. Here, MYC is linked to Familial prostate cancer.